Modern Immunological and Molecular Approaches to Species Identification

The precipitin test relies on polyclonal antisera raised in rabbits or other animals by repeated immunisation with proteins from the target species. When the antiserum meets the matching antigen in solution, immune complexes form and become insoluble, creating visible turbidity or a discrete precipitate line. The Uhlenhuth test, the ring precipitin test of Nuttall, and the Ouchterlony double-diffusion plate all work on this principle. The principal weaknesses are that the result is qualitative rather than quantitative, polyclonal antisera vary between batches, and the sensitivity threshold is relatively high, typically requiring at least several micrograms of protein.

ELISA overcomes most of these limitations. In the sandwich ELISA format used most commonly for species identification, a capture antibody specific to a target species protein (often human haemoglobin or human albumin) is coated onto the wells of a microtitre plate. Sample extract is added and any matching antigen binds the capture antibody. A second, enzyme-conjugated detection antibody is added. After washing, a substrate is added that the enzyme converts to a coloured product. Absorbance is read spectrophotometrically and compared to a standard curve. The detection limit for haemoglobin-based human blood ELISA is in the nanogram range, roughly 1000 times more sensitive than classical precipitin.

The transition from polyclonal to monoclonal antibodies was a second major improvement. Hybridoma technology, developed by Kohler and Milstein in 1975, allows the production of unlimited quantities of an antibody with defined and consistent specificity. A monoclonal antibody targeting a species-specific peptide sequence on haemoglobin or albumin performs identically across years and production batches. This consistency is particularly important in a forensic context where reagent variability could generate admissibility challenges.

Lateral-flow immunochromatographic devices were designed to give a qualitative yes-or-no answer within minutes using minimal equipment. The device consists of a nitrocellulose membrane strip with four functional zones: a sample application pad, a conjugate pad containing antibody labelled with colloidal gold or coloured latex particles, a test line bearing species-specific capture antibody, and a control line bearing antibody against the label or the detecting antibody. Sample extract is applied to the sample pad and migrates by capillary action.

If the target antigen is present, it binds the labelled antibody in the conjugate pad, and the complex is captured at the test line, producing a visible colour band. Unbound labelled antibody continues to the control line and is captured there, confirming that flow occurred and the reagents functioned. The result is interpreted as: two bands (test + control) = positive; one band (control only) = negative; no bands or control band absent = invalid test. A test with no control band must be repeated regardless of the test line result.

Several commercial strips were originally developed for human blood detection in forensic applications, including the Hexagon OBTI, ABAcard HemaTrace, and RSID-Blood (which detects human haemoglobin). These products are validated for casework use in multiple jurisdictions, including by the Scientific Working Group for Materials Analysis (SWGMAT) in the United States and under accreditation schemes governed by UKAS in the United Kingdom. They detect human blood down to approximately 1 in 10,000 dilution. Their limitation is specificity to human blood: non-human animal identification requires species-specific strips or a transition to ELISA with appropriate antisera.

A monoclonal antibody panel for species identification consists of a set of antibodies, each directed against a protein that is either unique to one species or that differs in sequence between species to a degree that allows antibody discrimination. Common target proteins include albumin, haemoglobin, immunoglobulin G, and species-specific serum proteins. The panel approach allows both positive identification of a suspected species and partial exclusion of others when assayed in parallel.

Cross-reactivity is the most significant analytical problem in antibody-based species identification. An antibody raised against human albumin may bind to albumin from chimpanzees, gorillas, and orangutans because these proteins share greater than 95% sequence identity with the human protein. This is not a defect in the antibody, it is a consequence of evolutionary conservation. In forensic practice, a positive human albumin ELISA result from a sample at a scene involving primate trade or captive great apes cannot be taken as unambiguous evidence of human blood. DNA analysis is required to resolve the species.

For non-human species panels, the forensic scientist selects target proteins that vary between taxa of interest. In wildlife casework, species of concern include deer, bear, rhinoceros, tiger, and various birds depending on the jurisdiction. Commercial ELISA kits exist for common livestock species (bovine, porcine, equine) driven by food safety demand. For less commercially supported species, bespoke antibodies can be raised using recombinant target proteins, but this requires specialist facilities and is uncommon in routine forensic laboratories.

DNA barcoding targets short, standardised regions of the mitochondrial genome that evolve at a predictable rate and are flanked by conserved primer-binding sites. The cytochrome c oxidase subunit I (COI) gene is the universal barcode for animals: a 648-base-pair region at the 5' end accumulates interspecific variation at roughly 10 times the rate of intraspecific variation, making species discrimination reliable across most animal taxa. For forensic trace evidence, shorter amplicons within the COI region or the 12S rRNA gene are used because degraded samples rarely yield intact 648-base-pair fragments.

The workflow is: extract DNA from the sample, amplify the target region by PCR using universal or group-specific primers, sequence the amplicon by Sanger or next-generation sequencing, and compare the sequence against reference databases. The Barcode of Life Data System (BOLD) and the NCBI GenBank both serve as reference resources. A sequence match at greater than 97 to 99% identity to a reference sequence is typically treated as a species identification, though the threshold depends on the taxonomic group and the coverage of the reference database.

The complementary relationship between immunological and DNA methods is most visible in conditions that degrade one approach more than the other. Proteins denature at temperatures above approximately 60 to 80 degrees Celsius and under strongly acidic or alkaline conditions. A bloodstain on a surface that has been exposed to fire, bleach, or direct sunlight for months may show false-negative or no result on ELISA yet still yield amplifiable mitochondrial DNA, because mitochondrial DNA is present in thousands of copies per cell and short amplicons survive conditions that destroy proteins. Conversely, DNA is more susceptible to some chemical environments, particularly those containing DNases, while certain structural proteins can survive for centuries in dry conditions. Using both methods provides mutual verification.

The forensic admissibility of DNA barcoding has been established in multiple jurisdictions. In the United States, COI barcoding evidence has been accepted in wildlife trafficking cases under Daubert and Frye standards in different circuits. In the UK, DNA-based species identification evidence is admissible under the common law rules governing expert opinion and has been used in cases prosecuted under the Wildlife and Countryside Act 1981 and the Control of Trade in Endangered Species (COTES) Regulations. In India, species identification by DNA is used in forest crime cases under the Wildlife Protection Act 1972, with reports typically prepared by the Wildlife Institute of India or accredited state forensic science laboratories.

Food fraud involving species substitution came to widespread public attention with the 2013 European horsemeat scandal, in which products labelled as beef were found to contain substantial proportions of horse meat. The analytical response drew on both ELISA and PCR-based species identification. ELISA kits targeting horse myosin or horse-specific proteins were used for rapid screening; PCR-based species ID using mitochondrial markers, primarily the cytochrome b gene, provided the confirmatory identification that underpinned enforcement action.

Regulatory frameworks vary by jurisdiction. In the EU, Regulation 1169/2011 on food information to consumers requires accurate species labelling of meat products. The European Union Reference Laboratory for food species identification maintains validated PCR and ELISA protocols. In the United States, the USDA Food Safety and Inspection Service maintains species verification methods for meat, and the FDA operates parallel programmes for seafood. In India, the Food Safety and Standards Authority of India (FSSAI) has issued protocols for species identification under the Food Safety and Standards Act 2006, including lateral-flow screening for adulteration of meat and dairy.

A consistent challenge in food matrix testing is the effect of processing on protein structure. Heat treatment, fermentation, high pressure, and emulsification can denature proteins and destroy antibody epitopes. Highly processed products such as sausages, pates, and dried meats require assay validation for the processed matrix, not just fresh tissue. DNA methods are more tolerant of food processing than protein methods because short mitochondrial amplicons can often be recovered from heavily processed products. For regulatory purposes, processed food matrices are routinely tested by both methods in parallel.

Forensic species identification results are only reliable if the assay has been formally validated for the matrix and the analytical purpose. Validation for a lateral-flow strip or ELISA used in casework typically includes: analytical sensitivity (lowest concentration giving a reliable positive), analytical specificity (panel of species tested for cross-reactivity), inclusivity (range of samples from within the target species that produce a positive), and robustness (performance on aged, mixed, or contaminated samples). International standards from ISO 17025 govern laboratory accreditation and apply to forensic species testing just as to any other analytical chemistry.

Controls are mandatory in every analytical run. A positive control containing a known quantity of the target antigen confirms that the reagents and procedure are working. A negative control containing only buffer or extract from a confirmed non-target species confirms the absence of carryover contamination. A method blank confirms reagent purity. In DNA-based methods, a no-template PCR control detects contamination. Missing or failing controls invalidate the run regardless of the sample results.

Reports of species identification results for forensic purposes must state the method used, the validation status of the method, any limitations relevant to the specific sample type, the result obtained, and the interpretation. Where DNA and immunological results are combined, the report should explain the relationship between the two results, including whether they are concordant, which takes precedence where they diverge, and why. In jurisdictions where chain of custody requirements apply to biological evidence, such as under the Bharatiya Nagarik Suraksha Sanhita 2023 in India or under Federal Rules of Evidence in the United States, the report should also confirm continuity of the sample from collection to analysis.

The history of forensic serology shows that even well-established methods can fail when applied outside their validated parameters. The precipitin test produced false positives from plant material in some early casework. ELISA kits validated for fresh human bloodstains may underperform on aged stains or non-standard substrates unless specifically validated for those conditions. Every new matrix, every novel substrate, and every significantly degraded sample is an opportunity for an assumption to fail. The forensic scientist's obligation is to state the assumption explicitly and to test it where possible.